Loading data...
Loading data...
$43.39 · Score 51/100
0 open-market purchases and 2 sales out of the last 2 Form 4 filings scanned for ALKS — open-market transactions only, sourced directly from official SEC EDGAR filings.
0
Buys
2
Sells
| Date | Insider | Ownership | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 3, 2026 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | — | Open Market Sale | 2,034 | $48.01 | $97.65K |
| Sep 1, 2026 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | — | Open Market Sale | 9,000 | $46.99 | $422.87K |
This information is based on official filings only and does not constitute investment advice. Insider transactions don't necessarily signal a stock's future direction — they can often stem from personal cash-flow needs, portfolio diversification, or tax planning.